Minding the heart: Why are we still not closer to treating depression and anxiety in clinical cardiology practice?

Abstract

Get full access to this article

View all access options for this article.

References

Lichtman

Froelicher

Blumenthal

et al.

Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: A scientific statement from the American Heart Association. Circulation 2014; 129: 1350–1369.

Pedersen

von Kanel

Tully

et al.

Psychosocial perspectives in cardiovascular disease. Eur J Prev Cardiol 2017; 24: 108–115.

Pogosova

Saner

Pedersen

et al.

Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol 2015; 22: 1290–1306.

Tully

Cosh

Baumeister

. The anxious heart in whose mind? A systematic review and meta-regression of factors associated with anxiety disorder diagnosis, treatment and morbidity risk in coronary heart disease. J Psychosom Res 2014; 77: 439–448.

Hoogwegt

Kupper

Theuns

et al.

Beta-blocker therapy is not associated with symptoms of depression and anxiety in patients receiving an implantable cardioverter-defibrillator. Europace 2012; 14: 74–80.

Huffman

Smith

Blais

et al.

Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. Am J Cardiol 2006; 98: 319–324.

Szpakowski

Qiu

Masih

et al.

Economic impact of subsequent depression in patients with a new diagnosis of stable angina: A population-based study. J Am Heart Assoc 2017; 6. DOI: 10.1161/JAHA.117.006911.

Cook

Cole

Asaria

et al.

The annual global economic burden of heart failure. Int J Cardiol 2014; 171: 368–376.

Luppa

Heinrich

Angermeyer

et al.

Cost-of-illness studies of depression: A systematic review. J Affect Disord 2007; 98: 29–43.

10.

Rodwin

Spruill

Ladapo

. Economics of psychosocial factors in patients with cardiovascular disease. Prog Cardiovasc Dis 2013; 55: 563–573.

11.

Michaud

Murray

Bloom

. Burden of disease – implications for future research. JAMA 2001; 285: 535–539.

12.

Flachs

Eriksen

Koch

et al.

Sygdomsbyrden i Danmark – sygdomme [Burden of disease in Denmark – diseases], Copenhagen: Danish Health Authority, 2015.

13.

Piepoli

Hoes

et al.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol 2016; 23: NP1–NP96.

14.

Perk

De Backer

Gohlke

et al.

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635–1701.

15.

Rozanski

. Behavioral cardiology: Current advances and future directions. J Am Coll Cardiol 2014; 64: 100–110.

16.

Mozaffarian

Benjamin

et al.

Writing Group Members. Heart disease and stroke statistics – 2016 update: A report from the American Heart Association. Circulation 2016; 133: e38–e360.

17.

Thombs

Roseman

Coyne

et al.

Does evidence support the American Heart Association’s recommendation to screen patients for depression in cardiovascular care? An updated systematic review. PLoS One 2013; 8: e52654–e52654.

18.

Thombs

de Jonge

Coyne

et al.

Depression screening and patient outcomes in cardiovascular care: A systematic review. JAMA 2008; 300: 2161–2171.

19.

Richards

Anderson

Jenkinson

et al.

Psychological interventions for coronary heart disease: Cochrane review and metaanalysis. Eur J Prev Cardiol. 2018; 25: 247–259.

20.

Whalley

Rees

Davies

et al.

Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2011, pp. CD002902–CD002902.

21.

Richards

Anderson

Jenkinson

et al.

Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2017; 4: CD002902–CD002902.

22.

Habibovic

Burg

Pedersen

. Behavioral interventions in patients with an implantable cardioverter defibrillator: Lessons learned and where to go from here? Pacing Clin Electrophysiol 2013; 36: 578–590.

23.

Andersson

Estling

Jakobsson

et al.

Can the patient decide which modules to endorse? An open trial of tailored internet treatment of anxiety disorders. Cogn Behav Ther 2011; 40: 57–64.

24.

Habibovic

Cuijpers

Alings

et al.

Attrition and adherence in a WEB-based distress management program for implantable cardioverter defibrillator patients (WEBCARE): Randomized controlled trial. J Med Internet Res 2014; 16: e52–e52.

25.

Havranek

Mujahid

Barr

et al.

Social determinants of risk and outcomes for cardiovascular disease: A scientific statement from the American Heart Association. Circulation 2015; 132: 873–898.

26.

Barley

Clifton

Lee

et al.

The space from heart disease intervention for people with cardiovascular disease and distress: A mixed-methods study. JMIR Res Protoc 2015; 4: e81–e81.

27.

Davidson

Bigger

Burg

et al.

Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med 2013; 173: 997–1004.

28.

Kronish

Chaplin

Rieckmann

et al.

The effect of enhanced depression care on anxiety symptoms in acute coronary syndrome patients: Findings from the COPES trial. Psychother Psychosom 2012; 81: 245–247.